Lv51
1582 积分 2025-03-25 加入
Rational design of selective bispecific EPO-R/CD131 agonists
15分钟前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
1个月前
已完结
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
2个月前
已完结
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
2个月前
已完结
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia
2个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
3个月前
已完结
MMRN1-EGFR drives sialylglycan-Siglec immune evasion in AML leukemia stem cells
6个月前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
9个月前
已完结
Circulating B Lymphocytes in Multiple Myeloma Patients Contain an Autocrine IL-6 Driven Pre-Myeloma Cell Population
10个月前
已完结
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
10个月前
已完结
皖公网安备34019202002308
